Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionMonetary Management Group Inc
Latest Disclosed Ownership1,259 shares
Latest Disclosed Value $ 192,312
Monetary Management Group Inc ownership in NVS / Novartis AG - Depositary Receipt (Common Stock)

On May 13, 2026 - Monetary Management Group Inc filed a 13F-HR form disclosing ownership of 1,259 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $192,312 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 1,259 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 0.00% during the quarter. The current value of the position is $186,836 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F Novartis COM 66987V109 1,259 0 0.00 192 10.98 0.0459
2026-02-11 2025-12-31 13F Novartis COM 66987V109 1,259 0 0.00 174 7.45 0.0401
2025-11-12 2025-09-30 13F Novartis COM 66987V109 1,259 0 0.00 161 5.92 0.0371
2025-08-14 2025-06-30 13F Novartis COM 66987V109 1,259 0 0.00 152 8.57 0.0375
2025-05-14 2025-03-31 13F Novartis COM 66987V109 1,259 0 0.00 140 14.75 0.0379
2025-02-13 2024-12-31 13F Novartis COM 66987V109 1,259 0 0.00 123 -15.28 0.0318
2024-11-13 2024-09-30 13F Novartis COM 66987V109 1,259 0 0.00 145 7.46 0.0372
2024-07-16 2024-06-30 13F Novartis COM 66987V109 1,259 0 0.00 134 10.74 0.0354
2024-05-13 2024-03-31 13F Novartis COM 66987V109 1,259 0 0.00 122 -4.72 0.0339
2024-02-14 2023-12-31 13F Novartis COM 66987V109 1,259 0 0.00 127 -0.78 0.0396
2023-11-09 2023-09-30 13F Novartis COM 66987V109 1,259 0 0.00 128 0.79 0.0427
2023-08-11 2023-06-30 13F Novartis COM 66987V109 1,259 0 0.00 127 10.43 0.0389
2023-05-11 2023-03-31 13F Novartis COM 66987V109 1,259 0 0.00 116 0.88 0.0341
2023-02-13 2022-12-31 13F Novartis COM 66987V109 1,259 0 0.00 114 18.75 0.0357
2022-11-14 2022-09-30 13F Novartis COM 66987V109 1,259 0 0.00 96 -9.43 0.0316
2022-08-11 2022-06-30 13F Novartis COM 66987V109 1,259 0 0.00 106 -3.64 0.0332
2022-05-12 2022-03-31 13F Novartis COM 66987V109 1,259 0 0.00 110 0.00 0.0291
2022-02-14 2021-12-31 13F Novartis COM 66987V109 1,259 0 0.00 110 6.80 0.0272
2021-11-12 2021-09-30 13F Novartis COM 66987V109 1,259 0 0.00 103 -10.43 0.0283
2021-08-12 2021-06-30 13F Novartis COM 66987V109 1,259 0 0.00 115 6.48 0.0347
2021-05-17 2021-03-31 13F Novartis COM 66987V109 1,259 -84 -6.25 108 -14.96 0.0340
2021-02-12 2020-12-31 13F Novartis COM 66987V109 1,343 0 0.00 127 8.55 0.0418
2020-11-12 2020-09-30 13F Novartis COM 66987V109 1,343 0 0.00 117 0.00 0.0417
2020-08-13 2020-06-30 13F Novartis COM 66987V109 1,343 0 0.00 117 5.41 0.0442
2020-05-14 2020-03-31 13F Novartis COM 66987V109 1,343 0 0.00 111 -12.60 0.0491
2020-02-13 2019-12-31 13F Novartis COM 66987V109 1,343 0 0.00 127 8.55 0.0464
2019-11-12 2019-09-30 13F Novartis COM 66987V109 1,343 0 0.00 117 -4.88 0.0443
2019-08-13 2019-06-30 13F Novartis COM 66987V109 1,343 0 0.00 123 -4.65 0.0472
2019-05-14 2019-03-31 13F Novartis COM 66987V109 1,343 0 0.00 129 12.17 0.0511
2019-02-13 2018-12-31 13F Novartis COM 66987V109 1,343 0 0.00 115 -0.86 0.0520
2018-11-13 2018-09-30 13F Novartis COM 66987V109 1,343 0 0.00 116 14.85 0.0443
2018-08-13 2018-06-30 13F Novartis COM 66987V109 1,343 -300 -18.26 101 -24.06 0.0412
2018-05-14 2018-03-31 13F Novartis COM 66987V109 1,643 0 0.00 133 -3.62 0.0551
2018-02-14 2017-12-31 13F Novartis COM 66987V109 1,643 0 0.00 138 -2.13 0.0556
2017-11-13 2017-09-30 13F Novartis COM 66987V109 1,643 0 0.00 141 2.92 0.0594
2017-08-14 2017-06-30 13F Novartis COM 66987V109 1,643 0 0.00 137 12.30 0.0560
2017-05-15 2017-03-31 13F Novartis COM 66987V109 1,643 0 0.00 122 1.67 0.0530
2017-02-13 2016-12-31 13F Novartis COM 66987V109 1,643 -350 -17.56 120 -23.57 0.0554
2016-11-10 2016-09-30 13F Novartis COM 66987V109 1,993 -350 -14.94 157 -18.65 0.0726
2016-08-12 2016-06-30 13F Novartis COM 66987V109 2,343 0 0.00 193 13.53 0.0898
2016-05-11 2016-03-31 13F Novartis COM 66987V109 2,343 -1,800 -43.45 170 -52.25 0.0827
2016-02-11 2015-12-31 13F Novartis COM 66987V109 4,143 0 0.00 356 -6.56 0.1705
2015-11-25 2015-09-30 13F Novartis COM 66987V109 4,143 1,000 31.82 381 23.30 0.1906
2015-08-11 2015-06-30 13F Novartis COM 66987V109 3,143 800 34.14 309 33.77 0.1394
2015-05-12 2015-03-31 13F Novartis COM 66987V109 2,343 75 3.31 231 10.00 0.1019
2015-02-12 2014-12-31 13F Novartis COM 66987V109 2,268 100 4.61 210 2.94 0.0933
2014-11-06 2014-09-30 13F Novartis COM 66987V109 2,168 1,168 116.80 204 124.18 0.0945
2014-08-12 2014-06-30 13F Novartis COM 66987V109 1,000 -1,750 -63.64 91 -61.11 0.0426
2014-05-08 2014-03-31 13F Novartis COM 66987V109 2,750 -1,000 -26.67 234 -22.26 0.1088
2014-02-14 2013-12-31 13F Novartis COM 66987V109 3,750 0 0.00 301 4.51 0.1395
2013-11-12 2013-09-30 13F Novartis COM 66987V109 3,750 250 7.14 288 16.60 0.1514
2013-08-14 2013-06-30 13F Novartis COM 66987V109 3,500 3,500 247 0.1352
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.